Abstract
Following a $50 million expansion of its active pharmaceutical ingredients facility in Charles City, Iowa, earlier this year, fine chemicals maker Cambrex is already considering its next expansion at the site as well as improvements at plants in Sweden and Italy. The firm said on an earnings conference call that it expects to announce the projects, likely to cost about $20 million, by the end of the year. CEO Steven Klosk noted that the new capacity in Charles City is filling up quickly.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
